Неоадъювантная химиотерапия с включением гемцитабина в лечении местнораспространенного рака шейки матки

Т Х Оздоева, Быков Дмитрий Александрович, A A Chekan et al. · Вестник РОНЦ им. Н. Н. Блохина РАМН · 2010

The purpose of this study was to evaluate prognostic value of germinal center differentiation markers in diffuse large B-cell lymphoma. Sixty-two adult patients with diffuse large B-cell lymphoma aged 15 to 81 years (median 54 years) were included in the study. Immunohistochemistry was made by standard methodology, statistical analysis of data was done using SPSS software. Gene expression analysis of germinal center differentiation markers was carried out in accordance with the 2004 immunohistochemical algorithm. Basing on expression of CD10 and transcription factors BCL-6 and MuM1 all cases of diffuse large B-cell lymphomas were divided into germinal center (GCB) and non-germinal (non-GCB) center subtypes. Clinical significance of tumor tissue immunohistochemical study with mandatory analysis of germinal center differentiation markers was assessed together with primary tumor morphology data. Diffuse large B-cell lymphoma immunohistochemical profile appeared not identifiable by morphology. Identification of diffuse large B-cell lymphoma subtypes by immunohistochemical algorithms discovered GCB-type in 32% and non-GCB-type in 68% of cases. Factors of good prognosis included centroblastic morphology, germinal center origin and nodal primary disease. Patients with extranodal primary disease had the best prognosis among cases with diffuse large B-cell lymphoma of mixed morphology.

Cited by 0 works.

Authors